NeoPhore Company

NeoPhore targets the dynamics of cancer neoantigen evolution and makes effective medicines that will become a key part of the next-generation of cancer immunotherapies.

Funding Status: N/A
Headquarters: Cambridge, Cambridgeshire, United Kingdom
Founded Date: 2017
Investor Type: N/A
Investment Stage: N/A
Technology: Drug Discovery
Employee Number: Undisclosed
Number Of Exists: N/A
Industry: Preventive Medicine